STOCK TITAN

Xometry, Inc. Financials

XMTR
FY2025 annual
Revenue $686.6M +25.9% YoY
Net Income -$61.7M -22.4% YoY
EPS (Diluted) Not reported for FY2025
Free Cash Flow -$24.1M +28.0% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Xometry, Inc. (XMTR) reported $686.6M in revenue for fiscal year 2025, up 25.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI XMTR FY2025

Rapid revenue scaling is steadily shrinking operating losses, but cash generation still trails because a thin cash cushion persists.

FY2025 marks a meaningful cash-conversion shift after several years of burn: operating cash flow improved from -$15.4M to $6.1M. Free cash flow still stayed at -$24.1M because capital spending rose to $30.2M, showing the business is closer to self-funding at the operating level even though reinvestment still absorbs cash.

From FY2023 to FY2025, higher volume pushed revenue from $463.4M to $686.6M, giving fixed costs more room to spread across the cost base. Operating margin improved to -6.6% from -15.9% while gross margin stayed broadly flat, a pattern that fits fixed-cost absorption more than a sudden change in unit economics.

The balance-sheet cushion is thinner than the current ratio suggests, despite sizeable current assets: cash was only $15.0M at FY2025 versus $53.4M two years earlier. At the same time, debt-to-equity climbed to 1.5x and the current ratio was still 3.8x, implying day-to-day liquidity depends more on collecting receivables than on cash already on hand as repeated losses shrink equity.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 49 / 100
Financial Health Score 49/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Xometry, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
33

Xometry, Inc. has an operating margin of -6.6%, meaning the company loses $7 on every $100 of revenue. This results in a profitability score of 33/100. This is up from -10.3% the prior year.

Growth
83

Xometry, Inc.'s revenue surged 25.9% year-over-year to $686.6M, reflecting rapid business expansion. This strong growth earns a score of 83/100.

Leverage
36

Xometry, Inc. has a moderate D/E ratio of 1.55. This balance of debt and equity financing earns a leverage score of 36/100.

Liquidity
84

With a current ratio of 3.76, Xometry, Inc. holds $3.76 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 84/100.

Cash Flow
19

While Xometry, Inc. generated $6.1M in operating cash flow, capex of $30.2M consumed most of it, leaving -$24.1M in free cash flow. This results in a low score of 19/100, reflecting heavy capital investment rather than weak cash generation.

Returns
40

Xometry, Inc. posts a -22.4% return on equity (ROE), meaning it loses $22 for every $100 of shareholders' equity. This results in a returns score of 40/100. This is down from -16.0% the prior year.

Altman Z-Score Safe
7.06

Xometry, Inc. scores 7.06, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($4.8B) relative to total liabilities ($427.0M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/7

Xometry, Inc. passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Mixed
N/A

Xometry, Inc. reported a net loss of $61.7M while generating $6.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Xometry, Inc. reported an operating loss of $45.5M against $4.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$686.6M
YoY+25.9%
5Y CAGR+37.2%

Xometry, Inc. generated $686.6M in revenue in fiscal year 2025. This represents an increase of 25.9% from the prior year.

EBITDA
-$26.8M
YoY+38.0%

Xometry, Inc.'s EBITDA was -$26.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 38.0% from the prior year.

Net Income
-$61.7M
YoY-22.4%

Xometry, Inc. reported -$61.7M in net income in fiscal year 2025. This represents a decrease of 22.4% from the prior year.

EPS (Diluted)

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$24.1M
YoY+28.0%

Xometry, Inc. recorded an outflow of $24.1M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 28.0% from the prior year.

Cash & Debt
$15.0M
YoY-32.5%
5Y CAGR-24.2%

Xometry, Inc. held $15.0M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Dividends Per Share

Not reported for fiscal year 2025.

Shares Outstanding

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
39.1%
YoY-0.4pp
5Y CAGR+15.6pp

Xometry, Inc.'s gross margin was 39.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.4 percentage points from the prior year.

Operating Margin
-6.6%
YoY+3.7pp
5Y CAGR+14.0pp

Xometry, Inc.'s operating margin was -6.6% in fiscal year 2025, reflecting core business profitability. This is up 3.7 percentage points from the prior year.

Net Margin
-9.0%
YoY+0.3pp
5Y CAGR+13.0pp

Xometry, Inc.'s net profit margin was -9.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.3 percentage points from the prior year.

Return on Equity
-22.4%
YoY-6.4pp

Xometry, Inc.'s ROE was -22.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 6.4 percentage points from the prior year.

Capital Allocation

R&D Spending
$46.8M
YoY+19.0%
5Y CAGR+30.9%

Xometry, Inc. invested $46.8M in research and development in fiscal year 2025. This represents an increase of 19.0% from the prior year.

Share Buybacks
$8.1M

Xometry, Inc. spent $8.1M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures
$30.2M
YoY+66.8%
5Y CAGR+48.4%

Xometry, Inc. invested $30.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 66.8% from the prior year.

XMTR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

XMTR annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19
Revenue$807.5M$686.6M+25.9%$545.5M+17.7%$463.4M+21.7%$380.9M+74.5%$218.3M+54.4%$141.4M+76.3%$80.2M
Cost of Revenue$494.6M$417.9M+26.7%$329.9M+15.7%$285.1M+21.4%$234.9M+45.7%$161.2M+49.1%$108.1M+65.1%$65.5M
Gross Profit$312.9M$268.8M+24.6%$215.6M+21.0%$178.3M+22.1%$146.0M+155.5%$57.1M+71.7%$33.3M+125.9%$14.7M
R&D Expenses$49.0M$46.8M+19.0%$39.3M+14.1%$34.5M+11.1%$31.0M+74.4%$17.8M+45.9%$12.2M+14.6%$10.6M
SG&A Expenses$83.7M$72.3M+11.3%$65.0M-8.4%$70.9M+21.8%$58.2M+66.7%$34.9M+190.1%$12.0M+50.3%$8.0M
Operating Income-$30.6M-$45.5M+18.9%-$56.1M+23.7%-$73.6M+4.6%-$77.1M-31.4%-$58.7M-100.9%-$29.2M+4.4%-$30.5M
Interest Expense$5.1M$4.9M+3.3%$4.8M-0.7%$4.8M+8.3%$4.4M+418.5%$852K-21.8%$1.1M+351.9%$241K
Income Tax$1.2M$589K+2904.8%-$21K+94.1%-$353K-1080.6%$36KN/AN/AN/A
Net Income-$30.8M-$61.7M-22.4%-$50.4M+25.3%-$67.5M+14.6%-$79.0M-28.7%-$61.4M-97.5%-$31.1M-0.3%-$31.0M
EPS (Diluted)N/A-$1.03+27.0%-$1.41+16.1%-$1.68-$2.33-$5.32N/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

XMTR Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

XMTR annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19
Total Assets$703.7M+3.5%$680.1M-3.9%$707.4M-3.6%$734.1M+46.1%$502.6M+464.9%$89.0MN/A
Current Assets$334.6M+2.2%$327.5M-8.1%$356.2M-8.0%$387.2M+136.9%$163.4M+110.5%$77.7MN/A
Cash & Equivalents$15.0M-32.5%$22.2M-58.4%$53.4M-18.6%$65.7M-23.9%$86.3M+44.1%$59.9MN/A
Inventory$3.9M+0.1%$3.9M+35.7%$2.9M+83.6%$1.6M-22.7%$2.0M-11.4%$2.3MN/A
Accounts Receivable$97.4M+31.6%$74.0M+5.5%$70.1M+42.3%$49.3M+52.0%$32.4M+122.5%$14.6MN/A
Goodwill$263.8M+0.4%$262.7M-0.1%$262.9M+1.9%$258.0M+1.3%$254.7M+30472.9%$833K-61.9%$2.2M
Total Liabilities$427.0M+17.1%$364.5M-3.3%$377.0M+4.0%$362.3M+369.9%$77.1M-61.5%$200.2MN/A
Current Liabilities$88.9M+18.9%$74.8M-10.1%$83.2M+29.9%$64.0M+12.3%$57.0M+48.6%$38.4MN/A
Total Equity$275.6M-12.4%$314.5M-4.5%$329.3M-11.2%$370.7M-12.7%$424.4M+481.5%-$111.2M-52.2%-$73.1M
Retained Earnings-$432.0M-16.7%-$370.3M-15.8%-$319.9M-26.7%-$252.4M-45.6%-$173.3M-54.8%-$112.0MN/A

Not reported in any period shown, so not listed: Long-Term Debt.

XMTR Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

XMTR annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19
Operating Cash Flow$27.7M$6.1M+139.6%-$15.4M+48.5%-$29.9M+52.3%-$62.6M+8.7%-$68.6M-211.0%-$22.0M+18.7%-$27.1M
Capital ExpendituresN/A$30.2M+66.8%$18.1M-2.1%$18.5M+35.4%$13.7M+118.0%$6.3M+49.5%$4.2M+55.6%$2.7M
Free Cash FlowN/A-$24.1M+28.0%-$33.5M+30.8%-$48.4M+36.6%-$76.2M-1.9%-$74.8M-185.2%-$26.2M+12.0%-$29.8M
Investing Cash Flow-$327.5M-$16.6M+17.6%-$20.2M-220.1%$16.8M+107.0%-$238.6M-12.2%-$212.7M-3289.6%$6.7M+383.8%-$2.4M
Financing Cash Flow$304.8M$2.9M-37.7%$4.6M+334.8%$1.1M-99.6%$281.0M-8.7%$307.8M+772.8%$35.3M-35.6%$54.7M
Share BuybacksN/A$8.1M$0$0N/AN/AN/AN/A

Not reported in any period shown, so not listed: Dividends Paid.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

XMTR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

XMTR annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19
Gross Margin39.1%-0.4pp39.5%+1.1pp38.5%+0.1pp38.3%+12.2pp26.2%+2.6pp23.5%+5.2pp18.4%
Operating Margin-6.6%+3.7pp-10.3%+5.6pp-15.9%+4.4pp-20.2%+6.6pp-26.9%-6.2pp-20.7%+17.4pp-38.1%
Net Margin-9.0%+0.3pp-9.2%+5.3pp-14.6%+6.2pp-20.7%+7.4pp-28.1%-6.1pp-22.0%+16.6pp-38.6%
Return on Equity-22.4%-6.4pp-16.0%+4.5pp-20.5%+0.8pp-21.3%-6.8pp-14.5%N/AN/A
Return on Assets-8.8%-1.4pp-7.4%+2.1pp-9.5%+1.2pp-10.8%+1.5pp-12.2%+22.7pp-34.9%N/A
Current Ratio3.76-0.6x4.38+0.1x4.28-1.8x6.05+3.2x2.87+0.8x2.02N/A
Debt-to-Equity1.55+0.4x1.160.0x1.14+0.2x0.98+0.8x0.18N/AN/A
FCF Margin-3.5%+2.6pp-6.1%+4.3pp-10.4%+9.6pp-20.0%+14.3pp-34.3%-15.7pp-18.6%+18.6pp-37.2%

Similar Companies

Frequently Asked Questions

What is Xometry, Inc.'s annual revenue?

Xometry, Inc. (XMTR) reported $686.6M in total revenue for fiscal year 2025. This represents a 25.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Xometry, Inc.'s revenue growing?

Xometry, Inc. (XMTR) revenue grew by 25.9% year-over-year, from $545.5M to $686.6M in fiscal year 2025.

Is Xometry, Inc. profitable?

No, Xometry, Inc. (XMTR) reported a net income of -$61.7M in fiscal year 2025, with a net profit margin of -9.0%.

Xometry, Inc. (XMTR) had EBITDA of -$26.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Xometry, Inc. (XMTR) had a gross margin of 39.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Xometry, Inc. (XMTR) had an operating margin of -6.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Xometry, Inc. (XMTR) had a net profit margin of -9.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Xometry, Inc. (XMTR) has a return on equity of -22.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Xometry, Inc. (XMTR) recorded an outflow of $24.1M in free cash flow during fiscal year 2025. This represents a 28.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Xometry, Inc. (XMTR) generated $6.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Xometry, Inc. (XMTR) had $703.7M in total assets as of fiscal year 2025, including both current and long-term assets.

Xometry, Inc. (XMTR) invested $30.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Xometry, Inc. (XMTR) invested $46.8M in research and development during fiscal year 2025.

Yes, Xometry, Inc. (XMTR) spent $8.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Xometry, Inc. (XMTR) had a current ratio of 3.76 as of fiscal year 2025, which is generally considered healthy.

Xometry, Inc. (XMTR) had a debt-to-equity ratio of 1.55 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Xometry, Inc. (XMTR) had a return on assets of -8.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Xometry, Inc. (XMTR) has an Altman Z-Score of 7.06, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Xometry, Inc. (XMTR) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Xometry, Inc. (XMTR) reported a net loss of $61.7M while generating $6.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Xometry, Inc. (XMTR) reported an operating loss of $45.5M against $4.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Xometry, Inc. (XMTR) scores 49 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top